183 related articles for article (PubMed ID: 35212195)
1. Obesity is associated with improved postoperative overall survival, independent of skeletal muscle mass in lung adenocarcinoma.
Lee JH; Yoon YC; Kim HS; Cha MJ; Kim JH; Kim K; Kim HS
J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1076-1086. PubMed ID: 35212195
[TBL] [Abstract][Full Text] [Related]
2. Increased adipose tissue is associated with improved overall survival, independent of skeletal muscle mass in non-small cell lung cancer.
Tao J; Fang J; Chen L; Liang C; Chen B; Wang Z; Wu Y; Zhang J
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2591-2601. PubMed ID: 37724690
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of body mass index in small-cell lung cancer: Exploring the relationship with skeletal muscle status.
Kwon YJ; Yoon YC; Kim HS; Cha MJ; Park S; Lee JH
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2939-2947. PubMed ID: 37986687
[TBL] [Abstract][Full Text] [Related]
4. Obesity paradox in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy.
Lee JH; Kang D; Ahn JS; Guallar E; Cho J; Lee HY
J Cachexia Sarcopenia Muscle; 2023 Dec; 14(6):2898-2907. PubMed ID: 37964713
[TBL] [Abstract][Full Text] [Related]
5. Obesity is Associated with Longer Survival Independent of Sarcopenia and Myosteatosis in Metastatic and/or Castrate-Resistant Prostate Cancer.
Xu MC; Huelster HL; Hatcher JB; Avulova S; Stocks BT; Glaser ZA; Moses KA; Silver HJ
J Urol; 2021 Mar; 205(3):800-805. PubMed ID: 33080148
[TBL] [Abstract][Full Text] [Related]
6. Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancer.
Kuroki LM; Mangano M; Allsworth JE; Menias CO; Massad LS; Powell MA; Mutch DG; Thaker PH
Ann Surg Oncol; 2015 Mar; 22(3):972-9. PubMed ID: 25190123
[TBL] [Abstract][Full Text] [Related]
7. Psoas muscle mass in patients undergoing lung cancer surgery: a prognostic difference between squamous cell carcinoma and adenocarcinoma.
Ozeki N; Kawaguchi K; Fukui T; Nakamura S; Hakiri S; Mori S; Goto M; Iwano S; Yokoi K; Chen-Yoshikawa TF
Int J Clin Oncol; 2020 May; 25(5):876-884. PubMed ID: 31955305
[TBL] [Abstract][Full Text] [Related]
8. Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy.
Dijksterhuis WPM; Pruijt MJ; van der Woude SO; Klaassen R; Kurk SA; van Oijen MGH; van Laarhoven HWM
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):199-206. PubMed ID: 30666831
[TBL] [Abstract][Full Text] [Related]
9. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
10. Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study.
Lee JH; Hyung S; Lee J; Choi SH
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 36002189
[TBL] [Abstract][Full Text] [Related]
11. Screening for low muscularity in colorectal cancer patients: a valid, clinic-friendly approach that predicts mortality.
Cespedes Feliciano EM; Avrutin E; Caan BJ; Boroian A; Mourtzakis M
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):898-908. PubMed ID: 30066490
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of sarcopenia and sarcopenic obesity in patients affected by oral squamous cell carcinoma: A retrospective single-center study.
Bonavolontà P; Improta G; Dell'Aversana Orabona G; Goglia F; Abbate V; Sorrentino A; Piloni S; Salzano G; Iaconetta G; Califano L
J Craniomaxillofac Surg; 2023 Jan; 51(1):7-15. PubMed ID: 36739189
[TBL] [Abstract][Full Text] [Related]
13. Preoperative paraspinous muscle sarcopenia and physical performance as prognostic indicators in non-small-cell lung cancer.
Tanaka S; Ozeki N; Mizuno Y; Nakajima H; Hattori K; Inoue T; Nagaya M; Fukui T; Nakamura S; Goto M; Sugiyama T; Nishida Y; Chen-Yoshikawa TF
J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):646-656. PubMed ID: 33665984
[TBL] [Abstract][Full Text] [Related]
14. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
15. Preoperative thoracic muscle area on computed tomography predicts long-term survival following pneumonectomy for lung cancer.
Troschel FM; Kuklinski MW; Knoll SJ; Best TD; Muniappan A; Gaissert HA; Fintelmann FJ
Interact Cardiovasc Thorac Surg; 2019 Apr; 28(4):542-549. PubMed ID: 30307497
[TBL] [Abstract][Full Text] [Related]
16. Mortality after radical cystectomy: impact of obesity versus adiposity after adjusting for skeletal muscle wasting.
Psutka SP; Boorjian SA; Moynagh MR; Schmit GD; Frank I; Carrasco A; Stewart SB; Tarrell R; Thapa P; Tollefson MK
J Urol; 2015 May; 193(5):1507-13. PubMed ID: 25464002
[TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle radiodensity is prognostic for survival in patients with advanced non-small cell lung cancer.
Sjøblom B; Grønberg BH; Wentzel-Larsen T; Baracos VE; Hjermstad MJ; Aass N; Bremnes RM; Fløtten Ø; Bye A; Jordhøy M
Clin Nutr; 2016 Dec; 35(6):1386-1393. PubMed ID: 27102408
[TBL] [Abstract][Full Text] [Related]
18. Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients.
Moon SW; Choi JS; Lee SH; Jung KS; Jung JY; Kang YA; Park MS; Kim YS; Chang J; Kim SY
Respir Res; 2019 Feb; 20(1):35. PubMed ID: 30767787
[TBL] [Abstract][Full Text] [Related]
19. Association of Adipopenia at Preoperative PET/CT with Mortality in Stage I Non-Small Cell Lung Cancer.
Choi H; Park YS; Na KJ; Park S; Park IK; Kang CH; Kim YT; Goo JM; Yoon SH
Radiology; 2021 Dec; 301(3):645-653. PubMed ID: 34609197
[TBL] [Abstract][Full Text] [Related]
20. Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer.
Caan BJ; Cespedes Feliciano EM; Prado CM; Alexeeff S; Kroenke CH; Bradshaw P; Quesenberry CP; Weltzien EK; Castillo AL; Olobatuyi TA; Chen WY
JAMA Oncol; 2018 Jun; 4(6):798-804. PubMed ID: 29621380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
